MK-677 Directly Activates Growth Hormone-Regulating Brain Neurons

MK-677 activates neurons in the hypothalamic arcuate nucleus in living animals, confirming the brain as a primary site of action for this oral GH secretagogue.

Bailey, A R et al.·Journal of neuroendocrinology·1998·Moderate EvidenceAnimal StudyAnimal Study
RPEP-00449Animal StudyModerate Evidence1998RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

MK-0677 induced c-Fos expression in arcuate nucleus neurons in vivo, confirming direct hypothalamic activation as a mechanism for its GH-releasing effect.

Key Numbers

How They Did This

In vivo rat study using systemic MK-0677 administration, immunohistochemistry for c-Fos (neuronal activation marker), and anatomical mapping of activated neurons in the hypothalamus.

Why This Research Matters

Confirming that MK-677 works through the hypothalamus (not just the pituitary) means it activates the body's natural GH-releasing pathway, which helps explain why it produces physiological pulsatile GH release rather than unnatural continuous elevation.

The Bigger Picture

MK-677 was one of the most promising oral GH secretagogues in development. Understanding that it works centrally through the arcuate nucleus — the brain's GH control center — validates that it integrates into the normal neuroendocrine axis rather than bypassing it, which has implications for its safety profile and physiological appropriateness.

What This Study Doesn't Tell Us

Rat model — human hypothalamic anatomy differs somewhat. c-Fos is an indirect marker of activation. Single time point analysis doesn't capture dynamic neuronal responses.

Questions This Raises

  • ?Does chronic MK-677 use alter arcuate nucleus neuron sensitivity over time?
  • ?Are the activated neurons GHRH-producing or NPY/AgRP neurons?
  • ?Does this central activation mechanism explain MK-677's effects on appetite and sleep?

Trust & Context

Key Stat:
Arcuate nucleus activation confirmed MK-677 induced c-Fos in hypothalamic neurons, proving central mechanism of GH-releasing action
Evidence Grade:
Well-designed in vivo neuroanatomy study with appropriate controls. Confirms a specific mechanism but limited to animal data.
Study Age:
Published in 1998 during peak MK-677 research activity. This mechanistic finding remains foundational to understanding how MK-677 stimulates GH release.
Original Title:
The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.
Published In:
Journal of neuroendocrinology, 10(2), 111-8 (1998)
Authors:
Bailey, A R(6), Smith, R G(15), Leng, G(8)
Database ID:
RPEP-00449

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is the arcuate nucleus and why does it matter?

The arcuate nucleus is a region in the hypothalamus that serves as the brain's control center for growth hormone release. It contains neurons that produce GHRH (which stimulates GH) and responds to feedback signals to regulate GH pulsatility.

How does MK-677 differ from injectable GH-releasing peptides?

MK-677 is orally active (taken by mouth) and non-peptide, while most GHRPs require injection. Despite this structural difference, MK-677 activates the same brain pathways and receptors as peptide GH secretagogues.

Read More on RethinkPeptides

Cite This Study

RPEP-00449·https://rethinkpeptides.com/research/RPEP-00449

APA

Bailey, A R; Smith, R G; Leng, G. (1998). The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.. Journal of neuroendocrinology, 10(2), 111-8.

MLA

Bailey, A R, et al. "The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.." Journal of neuroendocrinology, 1998.

RethinkPeptides

RethinkPeptides Research Database. "The nonpeptide growth hormone secretagogue, MK-0677, activat..." RPEP-00449. Retrieved from https://rethinkpeptides.com/research/bailey-1998-the-nonpeptide-growth-hormone

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.